Your browser doesn't support javascript.
loading
Successful treatment of refractory lung adenocarcinoma harboring a germline BRCA2 mutation with olaparib: A case report.
Zhang, Li; Wang, Jing; Cui, Ling-Zhi; Wang, Kai; Yuan, Ming-Ming; Chen, Rong-Rong; Zhang, Li-Jiao.
Afiliación
  • Zhang L; Department of Cadre Health, Shanxi Provincial Cancer Hospital, Taiyuan 030013, Shanxi Province, China.
  • Wang J; Department of Cadre Health, Shanxi Provincial Cancer Hospital, Taiyuan 030013, Shanxi Province, China.
  • Cui LZ; Department of Cadre Health, Shanxi Provincial Cancer Hospital, Taiyuan 030013, Shanxi Province, China.
  • Wang K; Department of Medicine, Geneplus-Beijing, Beijing 102206, China.
  • Yuan MM; Department of Medicine, Geneplus-Beijing, Beijing 102206, China.
  • Chen RR; Department of Medicine, Geneplus-Beijing, Beijing 102206, China.
  • Zhang LJ; Department of Cadre Health, Shanxi Provincial Cancer Hospital, Taiyuan 030013, Shanxi Province, China. zljsx66@126.com.
World J Clin Cases ; 9(25): 7498-7503, 2021 Sep 06.
Article en En | MEDLINE | ID: mdl-34616818
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Clin Cases Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: World J Clin Cases Año: 2021 Tipo del documento: Article País de afiliación: China